Inhaled glucocorticoids and COPD exacerbations.

Inhaled glucocorticoids and COPD exacerbations.

ग्रंथसूची विवरण
मुख्य लेखकों:	Brightling, C, Pavord, I, Bafadhel, M
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2015

समान संसाधन

Inhaled corticosteroids in COPD.
द्वारा: Brightling, C, और अन्य
प्रकाशित: (1999)

Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations
द्वारा: McKeever, T, और अन्य
प्रकाशित: (2018)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
द्वारा: Bafadhel, M, और अन्य
प्रकाशित: (2014)

COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition.
द्वारा: Saha, S, और अन्य
प्रकाशित: (2006)

Inhaled corticosteroids in COPD (multiple letters) [1]
द्वारा: Hart, S, और अन्य
प्रकाशित: (1999)

Aspergillus fumigatus during stable state and exacerbations of COPD.
द्वारा: Bafadhel, M, और अन्य
प्रकाशित: (2014)

The Use of Inhaled Corticosteroids to Prevent Acute Exacerbations of COPD: A Pro/Con Debate
द्वारा: Russell, R, और अन्य
प्रकाशित: (2019)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
द्वारा: Siddiqui, S, और अन्य
प्रकाशित: (2018)

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations.
द्वारा: Barker, B, और अन्य
प्रकाशित: (2015)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
द्वारा: Bafadhel, M, और अन्य
प्रकाशित: (2016)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
द्वारा: Siddiqui SH, और अन्य
प्रकाशित: (2018-11-01)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
द्वारा: Eltboli, O, और अन्य
प्रकाशित: (2014)

The Importance of Inhaler Adherence to Prevent COPD Exacerbations
द्वारा: Jose R. Jardim, और अन्य
प्रकाशित: (2019-04-01)

Exacerbations of COPD
द्वारा: Pavord ID, और अन्य
प्रकाशित: (2016-02-01)

Lung microbiome dynamics in COPD exacerbations
द्वारा: Wang, Z, और अन्य
प्रकाशित: (2016)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
द्वारा: Russell, R, और अन्य
प्रकाशित: (2019)

Is it time to give up on "self-management" of COPD exacerbations?
द्वारा: Ramakrishnan, S, और अन्य
प्रकाशित: (2020)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.
द्वारा: Siva, R, और अन्य
प्रकाशित: (2014)

COPD exacerbation phenotypes: The next frontier
द्वारा: Moran, A, और अन्य
प्रकाशित: (2019)

Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
द्वारा: Bafadhel M, और अन्य
प्रकाशित: (2015-06-01)

Biological exacerbation clusters demonstrate asthma and COPD overlap with distinct mediator and microbiome profiles
द्वारा: Ghebre, M, और अन्य
प्रकाशित: (2018)

Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
द्वारा: Bafadhel, M, और अन्य
प्रकाशित: (2011)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
द्वारा: Russell REK, और अन्य
प्रकाशित: (2019-05-01)

Benralizumab for the prevention of COPD exacerbations
द्वारा: Criner, G, और अन्य
प्रकाशित: (2019)

The role of CT scanning in multidimensional phenotyping of COPD.
द्वारा: Bafadhel, M, और अन्य
प्रकाशित: (2011)

Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
द्वारा: Helen F. Ashdown, और अन्य
प्रकाशित: (2021-02-01)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
द्वारा: Siva R, और अन्य
प्रकाशित: (2014-02-01)

Use of dry powder inhalers in acute exacerbations of asthma and COPD
द्वारा: Olof Selroos, और अन्य
प्रकाशित: (2009-04-01)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
द्वारा: Siva, R, और अन्य
प्रकाशित: (2007)

Prednisolone response in patients with COPD.
द्वारा: Pavord, I, और अन्य
प्रकाशित: (2004)

Eosinophils in COPD: just another biomarker?
द्वारा: Bafadhel, M, और अन्य
प्रकाशित: (2017)

Characterising non-eosinophilic COPD
द्वारा: Hambleton, K, और अन्य
प्रकाशित: (2015)

Cognitive function and inhaler technique following recovery from exacerbations of COPD
द्वारा: Benjamin E. Henkle, और अन्य
प्रकाशित: (2023-05-01)

COPD exacerbations: transforming outcomes through research
द्वारा: Hurst, JR, और अन्य
प्रकाशित: (2018)

Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST
द्वारा: McKeever, T, और अन्य
प्रकाशित: (2018)

Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study
द्वारा: Jing Zhang, और अन्य
प्रकाशित: (2018-04-01)

Blood eosinophil count and exacerbation risk in patients with COPD.
द्वारा: Kerkhof, M, और अन्य
प्रकाशित: (2017)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
द्वारा: Djamin, R, और अन्य
प्रकाशित: (2019)

Renaming COPD exacerbations: the UK respiratory nursing perspective
द्वारा: Christine Mwasuku, और अन्य
प्रकाशित: (2021-09-01)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
द्वारा: Vestbo J, और अन्य
प्रकाशित: (2019-04-01)